149 related articles for article (PubMed ID: 7591205)
1. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function.
Tartour E; Latour S; Mathiot C; Thiounn N; Mosseri V; Joyeux I; D'Enghien CD; Lee R; Debre B; Fridman WH
Int J Cancer; 1995 Oct; 63(2):205-12. PubMed ID: 7591205
[TBL] [Abstract][Full Text] [Related]
2. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
Elsässer-Beile U; Wetterauer U; Schultze-Seemann W; Gallati H; Mönting JS; von Kleist S
Cancer Immunol Immunother; 1996 Feb; 42(2):93-8. PubMed ID: 8620526
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Ulchaker J; Panuto J; Rayman P; Novick A; Elson P; Tubbs R; Finke JH; Bukowski RM
J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K
Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286
[TBL] [Abstract][Full Text] [Related]
8. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.
Steger GG; Pierce WC; Figlin R; Czernin J; Kaboo R; DeKernion JB; Okarma T; Belldegrun A
Clin Immunol Immunopathol; 1994 Aug; 72(2):237-47. PubMed ID: 8050198
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL
Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
[TBL] [Abstract][Full Text] [Related]
13. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
[TBL] [Abstract][Full Text] [Related]
14. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor.
Kudoh S; Stanley J; Edinger MG; Tubbs RR; Klein E; Bukowski RM; Finke JH
Int J Cancer; 1994 Aug; 58(3):369-75. PubMed ID: 8050820
[TBL] [Abstract][Full Text] [Related]
18. The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma.
Steger GG; Gnant MF; Djavanmard MP; Mader RM; Jakesz R; Pierce W; deKernion JB; Figlin R; Belldegrun A
J Cancer Res Clin Oncol; 1997; 123(6):317-24. PubMed ID: 9222297
[TBL] [Abstract][Full Text] [Related]
19. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
Kowalczyk D; Skorupski W; Kwias Z; Nowak J
Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
